BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30423315)

  • 21. Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry.
    Dite GS; Makalic E; Schmidt DF; Giles GG; Hopper JL; Southey MC
    Breast Cancer Res; 2012 Aug; 14(4):R122. PubMed ID: 22929433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.
    Prajzendanc K; Domagała P; Hybiak J; Ryś J; Huzarski T; Szwiec M; Tomiczek-Szwiec J; Redelbach W; Sejda A; Gronwald J; Kluz T; Wiśniowski R; Cybulski C; Łukomska A; Białkowska K; Sukiennicki G; Kulczycka K; Narod SA; Wojdacz TK; Lubiński J; Jakubowska A
    Int J Cancer; 2020 Mar; 146(5):1293-1298. PubMed ID: 31469414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
    Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
    JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.
    Pang D; Zhao Y; Xue W; Shan M; Chen Y; Zhang Y; Zhang G; Liu F; Li D; Yang Y
    Med Oncol; 2012 Sep; 29(3):1561-8. PubMed ID: 22076508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters.
    Al-Moghrabi N; Al-Showimi M; Al-Yousef N; Al-Shahrani B; Karakas B; Alghofaili L; Almubarak H; Madkhali S; Al Humaidan H
    Clin Epigenetics; 2018 Jul; 10(1):99. PubMed ID: 30049288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
    Wang T; McCullough LE; White AJ; Bradshaw PT; Xu X; Cho YH; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
    Cancer; 2019 Nov; 125(21):3836-3844. PubMed ID: 31402456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients.
    Chen J; Haanpää MK; Gruber JJ; Jäger N; Ford JM; Snyder MP
    Clin Cancer Res; 2019 Sep; 25(17):5301-5314. PubMed ID: 31175093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 dysfunction in sporadic basal-like breast cancer.
    Turner NC; Reis-Filho JS; Russell AM; Springall RJ; Ryder K; Steele D; Savage K; Gillett CE; Schmitt FC; Ashworth A; Tutt AN
    Oncogene; 2007 Mar; 26(14):2126-32. PubMed ID: 17016441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.
    Al-Moghrabi N; Nofel A; Al-Yousef N; Madkhali S; Bin Amer SM; Alaiya A; Shinwari Z; Al-Tweigeri T; Karakas B; Tulbah A; Aboussekhra A
    BMC Cancer; 2014 Nov; 14():830. PubMed ID: 25403427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy.
    Xu Y; Diao L; Chen Y; Liu Y; Wang C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Deng D; Narod SA; Xie Y
    Ann Oncol; 2013 Jun; 24(6):1498-505. PubMed ID: 23406733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
    Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
    Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
    Harahap WA; Sudji IR; Nindrea RD
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features.
    Shakeri H; Fakhrjou A; Nikanfar A; Mohaddes-Ardebili SM
    Clin Lab; 2016 Dec; 62(12):2333-2337. PubMed ID: 28164568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
    Hasan TN; Leena Grace B; Shafi G; Syed R
    Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.
    Wu HC; Southey MC; Hibshoosh H; Santella RM; Terry MB
    Anticancer Res; 2017 Feb; 37(2):659-664. PubMed ID: 28179314
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Khan F; Agarwal P; Gupta S; Maurya MK; Singh P; Agarwal A; Singh K; Sonkar AA; Goel MM
    Indian J Med Res; 2023 Jan; 158(1):47-54. PubMed ID: 37602586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.
    Dodova RI; Mitkova AV; Dacheva DR; Hadjo LB; Vlahova AI; -Hadjieva MST; Valev SS; Caulevska MM; Popova SD; Popov IE; Dikov TI; Sedloev TA; Ionkov AS; Timcheva KV; Christova SL; Kremensky IM; Mitev VI; Kaneva RP
    BMC Cancer; 2015 Jul; 15():523. PubMed ID: 26183948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan.
    Muhammad N; Azeem A; Bakar MA; Prajzendanc K; Loya A; Jakubowska A; Hamann U; Rashid MU
    Breast Cancer Res Treat; 2023 Nov; 202(2):377-387. PubMed ID: 37528266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased genomic burden of germline copy number variants is associated with early onset breast cancer: Australian breast cancer family registry.
    Walker LC; Pearson JF; Wiggins GA; Giles GG; Hopper JL; Southey MC
    Breast Cancer Res; 2017 Mar; 19(1):30. PubMed ID: 28302160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.